Centex Studies Revenue and Competitors
Estimated Revenue & Valuation
- Centex Studies's estimated annual revenue is currently $2.9M per year.
- Centex Studies's estimated revenue per employee is $162,000
Employee Data
- Centex Studies has 18 Employees.
- Centex Studies grew their employee count by -33% last year.
Centex Studies's People
Name | Title | Email/Phone |
---|---|---|
1 | Site Director | Reveal Email/Phone |
2 | Financial Assistant/Regulatory Coordinator/Data Entry Coordinator | Reveal Email/Phone |
3 | Clinical Research Coordinator | Reveal Email/Phone |
4 | Clinical Research Recruiter | Reveal Email/Phone |
Centex Studies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.9M | 32 | -9% | N/A | N/A |
#2 | $8.6M | 40 | -13% | N/A | N/A |
#3 | $10.4M | 48 | 17% | N/A | N/A |
#4 | $42.2M | 142 | 14% | N/A | N/A |
#5 | $10.6M | 49 | 26% | N/A | N/A |
#6 | $8M | 37 | 6% | N/A | N/A |
#7 | $4M | 21 | -5% | N/A | N/A |
#8 | $8.9M | 41 | -7% | N/A | N/A |
#9 | $10.8M | 50 | 0% | N/A | N/A |
#10 | $8M | 37 | -24% | N/A | N/A |
What Is Centex Studies?
Centex Studies is a site management organization with locations in Houston and McAllen, TX and Lake Charles, LA. Collectively our sites have been open over 10 years and have conducted over 350 clinical trials in various indications. We specialize in phase 2 and 3 trials, and have done indications in areas of Neurology, Family Practice, Pulmonology , Dermatology, Obstetrics/Gynecology, Psychiatry, and more. We are always looking for opportunities to broaden our horizons and further our research experience.
keywords:N/AN/A
Total Funding
18
Number of Employees
$2.9M
Revenue (est)
-33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.6M | 18 | N/A | N/A |
#2 | $1.6M | 18 | N/A | N/A |
#3 | $1.3M | 18 | N/A | N/A |
#4 | $21970M | 18 | -10% | N/A |
#5 | $2.5M | 18 | -18% | N/A |